As shown in Additional file 1: Figure S1, SAMD13 was upregulated in blood, brain, liver, and bone cancers, while downregulated in colon, breast, kidney, head and neck, tongue, thyroid, adrenal gland, pharynx, testis, and endometrial cancers. The gene discussed is SAMD13; the disease is endometrial cancer.